Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland
Search for other papers by Tiina Vesterinen in
Google Scholar
PubMed
Search for other papers by Teijo Kuopio in
Google Scholar
PubMed
Search for other papers by Maarit Ahtiainen in
Google Scholar
PubMed
Search for other papers by Aija Knuuttila in
Google Scholar
PubMed
Search for other papers by Harri Mustonen in
Google Scholar
PubMed
Search for other papers by Kaisa Salmenkivi in
Google Scholar
PubMed
Search for other papers by Johanna Arola in
Google Scholar
PubMed
Translational Cancer Medicine Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland
Search for other papers by Caj Haglund in
Google Scholar
PubMed
Introduction Pulmonary carcinoid (PC) tumors are low- and intermediate-grade neoplasms that are subdivided into typical carcinoid (TC) and atypical carcinoid (AC) based on the mitotic count and presence of necrosis ( 1 ). PCs belong to
Search for other papers by Samira M Sadowski in
Google Scholar
PubMed
Search for other papers by Emanuel Christ in
Google Scholar
PubMed
Search for other papers by Benoit Bédat in
Google Scholar
PubMed
Search for other papers by Attila Kollár in
Google Scholar
PubMed
Search for other papers by Wolfram Karenovics in
Google Scholar
PubMed
Search for other papers by Aurel Perren in
Google Scholar
PubMed
Search for other papers by Frédéric Triponez in
Google Scholar
PubMed
Search for other papers by on behalf of the SwissNET registry in
Google Scholar
PubMed
metastasizes locally to hilar lymph nodes, and also distally to other organs ( 5 ). Regarding the management of pulmonary carcinoids, Caplin and coworkers ( 6 ) have published a recent European Neuroendocrine Tumor Society expert consensus with
Department of Neuroscience DNS, University of Padova, Padova, Italy
Search for other papers by Filippo Ceccato in
Google Scholar
PubMed
Nuclear Medicine Unit, Department of Medicine – DIMED, University-Hospital of Padova, Padova, Italy
Padova Neuroscience Center PNC, University of Padova, Padova, Italy
Search for other papers by Diego Cecchin in
Google Scholar
PubMed
Search for other papers by Michele Gregianin in
Google Scholar
PubMed
Search for other papers by Giacomo Ricci in
Google Scholar
PubMed
Department of Mathematics ‘Tullio Levi-Civita’ DM, University of Padova, Padova, Italy
Search for other papers by Cristina Campi in
Google Scholar
PubMed
Search for other papers by Filippo Crimì in
Google Scholar
PubMed
Search for other papers by Marta Bergamo in
Google Scholar
PubMed
Search for other papers by Annibale Versari in
Google Scholar
PubMed
Search for other papers by Carmelo Lacognata in
Google Scholar
PubMed
Search for other papers by Federico Rea in
Google Scholar
PubMed
Search for other papers by Mattia Barbot in
Google Scholar
PubMed
Search for other papers by Carla Scaroni in
Google Scholar
PubMed
Introduction and aim
Ectopic ACTH secretion (EAS) is mostly secondary to thoracic/abdominal neuroendocrine tumours (NETs) or small cell-lung carcinoma (SCLC). We studied the diagnostic accuracy of CT with 68Ga-Dota derivatives (68Ga-SSTR) PET in localizing ACTH-secreting tumor in patients with EAS.
Materials and methods
68Ga-SSTR-PET/CT was performed and compared with the nearest enhanced CT in 18 cases (16 primary and 2 recurrent neoplasms). Unspecific, indeterminate and false-positive uptakes were assessed using conventional imaging, follow-up or histology.
Results
We diagnosed 13 thoracic (9 primary and 2 recurrent bronchial carcinoids, 2 SCLCs) and 1 abdominal (pancreatic NET) tumors. Eight ACTH-secreting tumors were promptly identified at EAS diagnosis (’overt’, four pulmonary carcinoids with two recurrences and two SCLC); six EAS have been discovered during the subsequent follow-up (’covert’, five bronchial carcinoids and one pancreatic NET). At the time of EAS diagnosis, imaging was able to correctly detect the ACTH-secreting tumour in 8/18 cases (6 new diagnosis and 2 recurrences). During the follow-up, six out of initially ten ‘occult’ cases became ‘covert’. At last available follow-up, CT and 68Ga-SSTR-PET/CT were able to diagnose 11/18 and 12/18 ACTH-secreting tumours, respectively (11/14 and 12/14 considering only overt and covert cases, respectively). Four cases have never been localized by conventional or nuclear imaging (’occult EAS’), despite an average follow-up of 5 years.
Conclusion
The 68Ga-SSTR-PET/CT is useful in localizing EAS, especially to enhance positive prediction of the suggestive CT lesions and to detect occult neoplasms.
Search for other papers by Sara Storvall in
Google Scholar
PubMed
Search for other papers by Helena Leijon in
Google Scholar
PubMed
Search for other papers by Eeva Ryhänen in
Google Scholar
PubMed
Search for other papers by Johanna Louhimo in
Google Scholar
PubMed
Search for other papers by Caj Haglund in
Google Scholar
PubMed
Search for other papers by Camilla Schalin-Jäntti in
Google Scholar
PubMed
Search for other papers by Johanna Arola in
Google Scholar
PubMed
previously used and verified ( 25 , 26 , 27 , 28 , 33 ) with Western blotting and/or in vitro somatostatin receptor autoradiography. The same antibodies have previously been used by our research group for a study on pulmonary carcinoid tumors ( 23 ) as
Search for other papers by B C M Hermans in
Google Scholar
PubMed
Search for other papers by J L Derks in
Google Scholar
PubMed
Search for other papers by H J M Groen in
Google Scholar
PubMed
Search for other papers by J A Stigt in
Google Scholar
PubMed
Search for other papers by R J van Suylen in
Google Scholar
PubMed
Search for other papers by L M Hillen in
Google Scholar
PubMed
Search for other papers by E C van den Broek in
Google Scholar
PubMed
Search for other papers by E J M Speel in
Google Scholar
PubMed
Search for other papers by A-M C Dingemans in
Google Scholar
PubMed
L Fisseler-Eckhoff A Jonigk D Keller M Ott G Rieker RJ Sinn P Soder S Soltermann A , Interobserver agreement of proliferation index (Ki-67) outperforms mitotic count in pulmonary carcinoids . Virchows Archiv 2013 507 – 513
Search for other papers by Erik Rösner in
Google Scholar
PubMed
Search for other papers by Daniel Kaemmerer in
Google Scholar
PubMed
Search for other papers by Elisa Neubauer in
Google Scholar
PubMed
Search for other papers by Jörg Sänger in
Google Scholar
PubMed
Search for other papers by Amelie Lupp in
Google Scholar
PubMed
H Salmenkivi K Arola J Haglund C PD-1 and PD-L1 expression in pulmonary carcinoid tumors and their association to tumor spread . Endocrine Connections 2019 8 1168 – 1175 . ( https://doi.org/10.1530/EC-19-0308 ) 31 Tsao MS Kerr KM
Search for other papers by Kjell Oberg in
Google Scholar
PubMed
Search for other papers by Eric Krenning in
Google Scholar
PubMed
Search for other papers by Anders Sundin in
Google Scholar
PubMed
Search for other papers by Lisa Bodei in
Google Scholar
PubMed
Search for other papers by Mark Kidd in
Google Scholar
PubMed
Search for other papers by Margot Tesselaar in
Google Scholar
PubMed
Search for other papers by Valentina Ambrosini in
Google Scholar
PubMed
Search for other papers by Richard P Baum in
Google Scholar
PubMed
Search for other papers by Matthew Kulke in
Google Scholar
PubMed
Search for other papers by Marianne Pavel in
Google Scholar
PubMed
Search for other papers by Jaroslaw Cwikla in
Google Scholar
PubMed
Search for other papers by Ignat Drozdov in
Google Scholar
PubMed
Search for other papers by Massimo Falconi in
Google Scholar
PubMed
Search for other papers by Nicola Fazio in
Google Scholar
PubMed
Search for other papers by Andrea Frilling in
Google Scholar
PubMed
Search for other papers by Robert Jensen in
Google Scholar
PubMed
Search for other papers by Klaus Koopmans in
Google Scholar
PubMed
Search for other papers by Tiny Korse in
Google Scholar
PubMed
Search for other papers by Dik Kwekkeboom in
Google Scholar
PubMed
Search for other papers by Helmut Maecke in
Google Scholar
PubMed
Search for other papers by Giovanni Paganelli in
Google Scholar
PubMed
Search for other papers by Ramon Salazar in
Google Scholar
PubMed
Search for other papers by Stefano Severi in
Google Scholar
PubMed
Search for other papers by Jonathan Strosberg in
Google Scholar
PubMed
Search for other papers by Vikas Prasad in
Google Scholar
PubMed
Search for other papers by Aldo Scarpa in
Google Scholar
PubMed
Search for other papers by Ashley Grossman in
Google Scholar
PubMed
Search for other papers by Annemeik Walenkamp in
Google Scholar
PubMed
Search for other papers by Mauro Cives in
Google Scholar
PubMed
Search for other papers by Irene Virgolini in
Google Scholar
PubMed
Search for other papers by Andreas Kjaer in
Google Scholar
PubMed
Search for other papers by Irvin M Modlin in
Google Scholar
PubMed
neuroendocrine tumors and pulmonary carcinoids . Frontiers of Hormone Research 2015 44 115 – 138 . ( doi:10.1159/000382138 ) 39 Banck MS Kanwar R Kulkarni AA Boora GK Metge F Kipp BR Zhang L Thorland EC Minn KT Tentu
Search for other papers by E T Aristizabal Prada in
Google Scholar
PubMed
Search for other papers by C J Auernhammer in
Google Scholar
PubMed
expression, suppressed cell growth and caused cell cycle arrest because of a p21 and p27 increase and a cyclin D1 degradation in neuroendocrine gastrointestinal and pulmonary carcinoid cells in vitro ( 172 ). In addition, VPA also suppressed growth of